CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer

被引:202
作者
Turcotte, Martin [1 ,2 ,3 ]
Spring, Kathleen [1 ,2 ]
Pommey, Sandra [1 ,2 ]
Chouinard, Guillaume [1 ,2 ]
Cousineau, Isabelle [1 ,2 ]
George, Joshy [4 ]
Chen, Gregory M. [5 ,6 ]
Gendoo, Deena M. A. [5 ,6 ]
Haibe-Kains, Benjamin [5 ,6 ]
Karn, Thomas [7 ]
Rahimi, Kurosh [1 ,8 ,9 ]
Le Page, Cecile [1 ,2 ]
Provencher, Diane [1 ,2 ,9 ,10 ]
Mes-Masson, Anne-Marie [1 ,2 ,9 ,10 ]
Stagg, John [1 ,2 ,3 ]
机构
[1] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ H2X 0A9, Canada
[2] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada
[3] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
[4] Jackson Lab Genom Med, Computat Sci & Stat Anal, Farmington, CT USA
[5] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[6] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[7] Univ Hosp Frankfurt, Dept Obstet & Gynecol, Frankfurt, Germany
[8] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada
[9] Ctr Hosp Univ Montreal, Dept Pathol, Montreal, PQ H2X 0A9, Canada
[10] Univ Montreal, Dept Obstet & Gynecol, Div Gynecol Oncol, Montreal, PQ, Canada
关键词
NEGATIVE BREAST-CANCER; T-CELLS; TARGETING CD73; TUMOR-GROWTH; CARCINOMA; EXPRESSION; ADENOSINE; SURVIVAL; STAGE; DIFFERENTIATION;
D O I
10.1158/0008-5472.CAN-14-3569
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The cell surface nucleotidase CD73 is an immunosuppressive enzyme involved in tumor progression and metastasis. Although preclinical studies suggest that CD73 can be targeted for cancer treatment, the clinical impact of CD73 in ovarian cancer remains unclear. In this study, we investigated the prognostic value of CD73 in high-grade serous (HGS) ovarian cancer using gene and protein expression analyses. Our results demonstrate that high levels of CD73 are significantly associated with shorter disease-free survival and overall survival in patients with HGS ovarian cancer. Furthermore, high levels of CD73 expression in ovarian tumor cells abolished the good prognosis associated with intraepithelial CD8(+) cells. Notably, CD73 gene expression was highest in the C1/stromal molecular subtype of HGS ovarian cancer and positively correlated with an epithelial-to-mesenchymal transition gene signature. Moreover, in vitro studies revealed that CD73 and extracellular adenosine enhance ovarian tumor cell growth as well as expression of antiapoptotic BCL-2 family members. Finally, in vivo coinjection of ID8 mouse ovarian tumor cells with mouse embryonic fibroblasts showed that CD73 expression in fibroblasts promotes tumor immune escape and thereby tumor growth. In conclusion, our study highlights a role for CD73 as a prognostic marker of patient survival and also as a candidate therapeutic target in HGS ovarian cancers. (C) 2015 AACR.
引用
收藏
页码:4494 / 4503
页数:10
相关论文
共 40 条
[1]   PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction [J].
Abiko, Kaoru ;
Mandai, Masaki ;
Hamanishi, Junzo ;
Yoshioka, Yumiko ;
Matsumura, Noriomi ;
Baba, Tsukasa ;
Yamaguchi, Ken ;
Murakami, Ryusuke ;
Yamamoto, Ayaka ;
Kharma, Budiman ;
Kosaka, Kenzo ;
Konishi, Ikuo .
CLINICAL CANCER RESEARCH, 2013, 19 (06) :1363-1374
[2]   Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer [J].
Allard, Bertrand ;
Turcotte, Martin ;
Stagg, John .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (08) :863-881
[3]   Anti-CD73 therapy impairs tumor angiogenesis [J].
Allard, Bertrand ;
Turcotte, Martin ;
Spring, Kathleen ;
Pommey, Sandra ;
Royal, Isabelle ;
Stagg, John .
INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (06) :1466-1473
[4]   Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs [J].
Allard, Bertrand ;
Pommey, Sandra ;
Smyth, Mark J. ;
Stagg, John .
CLINICAL CANCER RESEARCH, 2013, 19 (20) :5626-5635
[5]   Epithelial-Mesenchymal Transition-Derived Cells Exhibit Multilineage Differentiation Potential Similar to Mesenchymal Stem Cells [J].
Battula, Venkata Lokesh ;
Evans, Kurt William ;
Hollier, Brett George ;
Shi, Yuexi ;
Marini, Frank C. ;
Ayyanan, Ayyakkannu ;
Wang, Rui-Yu ;
Brisken, Cathrin ;
Guerra, Rudy ;
Andreeff, Michael ;
Mani, Sendurai A. .
STEM CELLS, 2010, 28 (08) :1435-1445
[6]   Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors [J].
Beavis, Paul A. ;
Divisekera, Upulie ;
Paget, Christophe ;
Chow, Melvyn T. ;
John, Liza B. ;
Devaud, Christel ;
Dwyer, Karen ;
Stagg, John ;
Smyth, Mark J. ;
Darcy, Phillip K. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (36) :14711-14716
[7]   Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss [J].
Clarke, Blaise ;
Tinker, Anna V. ;
Lee, Cheng-Han ;
Subramanian, Subbaya ;
van de Rijn, Matt ;
Turbin, Dmitry ;
Kalloger, Steve ;
Han, Guangming ;
Ceballos, Kathy ;
Cadungog, Mark G. ;
Huntsman, David G. ;
Coukos, George ;
Gilks, C. Blake .
MODERN PATHOLOGY, 2009, 22 (03) :393-402
[8]   Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance [J].
Davidowitz, Rachel A. ;
Selfors, Laura M. ;
Iwanicki, Marcin P. ;
Elias, Kevin M. ;
Karst, Alison ;
Piao, Huiying ;
Ince, Tan A. ;
Drage, Michael G. ;
Dering, Judy ;
Konecny, Gottfried E. ;
Matulonis, Ursula ;
Mills, Gordon B. ;
Slamon, Dennis J. ;
Drapkin, Ronny ;
Brugge, Joan S. .
JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (06) :2611-2625
[9]   Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors [J].
Duraiswamy, Jaikumar ;
Kaluza, Karen M. ;
Freeman, Gordon J. ;
Coukos, George .
CANCER RESEARCH, 2013, 73 (12) :3591-3603
[10]   The Carcinoma-Associated Fibroblast Expressing Fibroblast Activation Protein and Escape from Immune Surveillance [J].
Fearon, Douglas T. .
CANCER IMMUNOLOGY RESEARCH, 2014, 2 (03) :187-193